Almotriptan in triptan-naïve patients: New evidence of benefits

Cephalalgia

Volumn 28, Issue SUPPL. 2, 2008, Pages 14-20

  Pascual, J ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Almotriptan; Migraine; Step care; Stratified care; Triptan

Indexed keywords

ALMOTRIPTAN; ANALGESIC AGENT; ANTIEMETIC AGENT; ERGOTAMINE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; TRIPTAN DERIVATIVE;

ANALGESIA; CLINICAL TRIAL; CONSULTATION; DRUG CHOICE; DRUG EFFICACY; DRUG RESPONSE; HUMAN; MIGRAINE; PATIENT ATTITUDE; PATIENT SATISFACTION; POST HOC ANALYSIS; PRESCRIPTION; RECURRENT DISEASE; REVIEW; SALVAGE THERAPY; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS AS TOPIC; DISEASE MANAGEMENT; EUROPE; HUMANS; META-ANALYSIS AS TOPIC; MIGRAINE DISORDERS; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 48249097975     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01686.x     Document Type: Review

References (16)

1. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation survey. Headache 2003 43 : 19 26.
2. Edmeads J. Understanding the needs of migraine patients. Drugs 2006 66 (Suppl. 3 1 8.
3. Pascual J, Leira R, Láinez JM, Alberca R, Titus F, Morales F et al. Estudio español de calidad de vida la migraña (II). Patrón de consumo de fármacos y eficacia subjetiva. Neurologia 1999 14 : 204 9.
4. Ceballos Hernansanz MA, Sanchez RR, Cano Orgaz A, Lopez-Gil A. Migraine treatment patterns and patient satisfaction with prior therapy: a substudy of a multicenter trial of rizatriptan effectiveness. Clin Ther 2003 25 : 2053 69.
5. Solomon S, Frishberg B, Hu XH, Markson L, Berger M. Migraine treatment outcomes with rizatriptan in triptan-naïve patients: a naturalistic study. Clin Ther 2001 23 : 886 900.
6. Lipton RB, Scher AI, Steiner TJ, Bigal ME, Kolodner K, Liberman JN, Stewart WF. Patterns of health care utilization for migraine in England and in the United States. Neurology 2003 60 : 441 8.
7. Lucas C, Chaffaut C, Artaz M-A, Lanteri-Minet M. FRAMIG 2000: medical and therapeutic management of migraine in France. Cephalalgia 2005 25 : 267 79.
8. European Headache Foundation. EHF/WHA Rome Declaration on Migraine WWW document]. URL http://www.ehf-org.org/pdf/WHA_EHF_DeclarationRome.pdf (accessed 6 November 2007).
9. Almirall. Data on file.
10. Lipton RB. Disability assessment as a basis for stratified care. Cephalalgia 1998 18 : 40 3.
11. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001 358 : 1668 75.
12. Dodick DW, Sandrini G, Williams P. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. CNS Drugs 2007 21 : 73 82.
13. Martin VT, Valade D, Almas M, Hettiarachchi J, Sikes C, Albert KS, Parsons B. Efficacy of eletriptan in triptan-naïve patients: results of a combined analysis. Headache 2007 47 : 181 8.
14. Diez FI, Straube A, Zanchin G. Patient preference in migraine therapy: a randomized, open-level, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan. J Neurol 2007 254 : 242 9.
15. Goadsby PJ, Massiou H, Pascual J, Diener HC, Dahlof CG, Mateos V et al. Almotriptan and zolmitriptan in the acute treatment of migraine. Acta Neurol Scand 2007 115 : 34 40.
16. Goadsby PJ, Zanchin G, Geraud G, de Klippel N, Diaz-Insa S, Gobel H et al. Early versus non-early intervention in acute migraine - 'Act when Mild' (AwM). A double-blind placebo-controlled trial of almotriptan. Cephalalgia 2008 28 : 383 91.